Programmed cell death protein-1 (PD-1) and its ligand, programmed death-ligand 1 (PD-L1), are immune checkpoint proteins that play critical roles in the immune modulation of tumour progression in a wide variety of tumour types [1, 2], making them suitable targets for cancer immunotherapy. Here, PDCD1 is linked to neoplasm.